Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A(2)A and A(3) adenosine receptor ligands. (49/50)

 (+info)

Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometry. (50/50)

 (+info)